- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04107532
Cognitive Behavioral Therapy Based on Virtual Reality and Biofeedback Technology (VRET)
September 25, 2019 updated by: Chun Wang, Nanjing Medical University
The subjects were randomly assigned to VR treatment group and imaginary leak treatment group.
In the VR treatment group, there were six VR exposure experiences, ranging from low to high levels of exposure, about 20 minutes each time, twice a week.
During the course of treatment, physiological data such as skin electricity, skin temperature, heart rate and blood volume were measured, and the state of the subjects was evaluated more objectively.
At the same time, every two minutes, the participants were asked the SUD value and recorded.
AQ, ATHQ and BAT were recorded before treatment, after treatment and during the follow-up period of six months.
The two groups were treated differently.
n addition, at the beginning of this treatment program, an experimental study was added to understand the eye movement characteristics of patients with acrophobia.
By viewing a group of high-altitude pictures, recording their eye movement characteristics and physiological feedback data, and scoring the anxiety level of each picture, and joining the normal control group, we can find a group of high-altitude pictures which can cause high-altitude fear in patients with high-altitude fear, and lay a foundation for future related research.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The study recruited 60 patients with Acrophobia and randomly assigned them to the VR treatment group and the imaginary exposure treatment group.
Recruitment conditions for Acrophobia: The Acrophobia questionnaire scored more than 45.45 points; Age 18-55 years old; Right-handedness; No psychotherapy or psychiatric medication for six months; Normal vision or corrective vision; Not during pregnancy or lactation.
Before the formal treatment, the participants were interviewed, mainly to understand in detail the fear of heights in the subjects, and to tell the subjects the reasons for the fear of heights and the principles of our treatment.
After confirming the participants 'intention to participate in the treatment, a heart test was conducted to eliminate heart problems and finally sign an informed consent form.
At the end of the interview, pre-tests were performed to collect fear of heights questionnaires, high attitude questionnaires, behavioral avoidance tests, and nuclear magnetic data collection.
There were a total of 5 treatments in the VR treatment group, followed by cliffs, cliffs, cliffs, single-plank bridges, and high-altitude rescues.
The difficulty of the scene increased in turn.
The frequency of treatment twice a week, about 30 minutes each time, fills in the motion sickness questionnaire before and after each treatment to understand the safety of VR treatment.
In the course of treatment, physiological data such as skin electricity, skin temperature, heart rate, and blood volume were measured, and the state of the subjects was objectively evaluated.
At the same time, every two minutes, participants were asked about sud values and recorded.
Visualizing exposure therapy is to achieve the goal of exposure by transforming the five scenes of VR exposure therapy through language and guiding the subjects through the guidance language.
Both treatment groups were required to collect scales and nuclear magnetic data before, after and after six months of follow-up.
In addition, at the beginning of this treatment program, an experimental study was added to understand the characteristics of eye movement in people with anorexia.
By looking at high altitude images, recording their eye movement characteristics and physiological feedback, and rating the anxiety levels of each image, adding to the normal control group, we found a high altitude image that can cause high altitude fear in people with high altitude fear.
And lay the foundation for future related research.
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chun Wang, doc.
- Phone Number: 15850566376
- Email: fm51109@163.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
1.18-55 years old; 2.The anxiety scale in AQ scored more than 45.45 points ; 3.Meeting the DSM-IV criteria for specific phobia.
Exclusion Criteria:
- Other current or recent mental disorders, such as post-traumatic stress disorder;
- Other physical diseases (such as heart disease and epilepsy) that may affect treatment;
- Pregnancy or lactation;
- No effect of psychotropic drugs or psychotherapy or prior exposure to heightphobia within 6 months (2013).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Virtual Reality Therapy for Acrophobia
There were a total of 5 treatments in the VR treatment group, followed by cliffs, cliffs, cliffs, single-plank bridges, and high-altitude rescues.
The difficulty of the scene increased in turn.
The frequency of treatment twice a week, about 30 minutes each time, fills in the motion sickness questionnaire before and after each treatment to understand the safety of VR treatment.
In the course of treatment, physiological data such as skin electricity, skin temperature, heart rate, and blood volume were measured, and the state of the subjects was objectively evaluated.
At the same time, every two minutes, participants were asked about sud values and recorded.
|
Virtual Reality Therapy and Imagination Exposure Therapy
|
OTHER: Imagination Exposure Therapy for Acrophobia
The imaginary exposure treatment program is to convert the five scenes of VR exposure treatment through language, guide the subjects through the guidance language, guide the subjects to expose, and achieve the purpose of adaptation.
Both treatment groups were required to collect scales and nuclear magnetic data before, after and after six months of follow-up.
|
Virtual Reality Therapy and Imagination Exposure Therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
AQ
Time Frame: 3 weeks
|
There were a total of 20 questions on the anxiety scale in the Acrophobia Questionnaire.
Each topic scored 0-6 points.
More than 45.45 points were included in the group to assess the differences in scores between the subjects before and after treatment.
|
3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Chun Wang, doc., Nanjing Brain Hospital Nanjing, Jiangsu China
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
October 1, 2019
Primary Completion (ANTICIPATED)
October 1, 2019
Study Completion (ANTICIPATED)
October 1, 2020
Study Registration Dates
First Submitted
September 4, 2019
First Submitted That Met QC Criteria
September 25, 2019
First Posted (ACTUAL)
September 27, 2019
Study Record Updates
Last Update Posted (ACTUAL)
September 27, 2019
Last Update Submitted That Met QC Criteria
September 25, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 2016-KY095
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Virtual Reality Exposure Therapy
-
Laboratoire de Psychologie des CognitionsUniversity Hospital, Strasbourg, France; ICube Laboratory - Team IGG; Ithaque... and other collaboratorsCompletedCocaine Use Disorder | Virtual Reality Exposure TherapyFrance
-
Shanghai Mental Health CenterRecruitingA Preliminary Study on the Intervention Effect of Virtual Reality Exposure Therapy on Fear of FlyingFear of Flying | Virtual Reality Exposure TherapyChina
-
Stanford UniversityNational Cancer Institute (NCI)CompletedSmoking Cessation | MindCotine Virtual Reality Mindful Exposure TherapyUnited States
-
Poitiers University HospitalCompletedPain | Anxiety | Virtual Reality | Virtual Reality Exposure Therapy | SalpingographyFrance
-
University of BarcelonaNot yet recruitingAnxiety | Randomized Controlled Trial | Virtual Reality Exposure Therapy | AerophobiaSpain
-
Barron Associates, Inc.Duke University; University of VirginiaRecruitingVirtual Reality | Occupational TherapyUnited States
-
National Taiwan Normal UniversityCompleted
-
Centre Antoine LacassagneRecruitingPediatric Cancer | Virtual Reality | Proton TherapyFrance
-
University of WashingtonNational Institutes of Health (NIH)UnknownVirtual Reality TherapyUnited States
-
Erasme University HospitalCompletedPropofol | Conscious Sedation | Remifentanil | Virtual Reality Therapy | Fertilization in VitroBelgium
Clinical Trials on Virtual Reality Therapy and Imagination Exposure Therapy
-
Luxembourg Institute of HealthCentre Hospitalier du LuxembourgCompleted
-
VU University of AmsterdamCompletedSocial Anxiety Disorder | Social PhobiaNetherlands
-
Tomorrow Sp. z o.o.National Center for Research and Development, PolandCompleted
-
Georgia State UniversityVirtually Better, Inc.CompletedSocial Anxiety DisorderUnited States
-
University of Notre DameCompletedSpecific Phobia | Anxiety Disorder | Fear of Heights | AcrophobiaUnited States
-
Weill Medical College of Cornell UniversityCornell UniversityRecruitingPosttraumatic Stress DisorderUnited States
-
Johns Hopkins UniversityCompletedSpecific Phobia | Specific Phobia, Animal | Specific Phobia, Situational | Specific Phobia, Natural Environment | Childhood Anxiety DisorderUnited States
-
Stockholm UniversityCompletedAnxiety | Social Phobia | Behavior TherapySweden
-
Stockholm UniversityPBM; MimerseCompletedSocial Anxiety | Public Speaking | Social Anxiety Disorder, Performance OnlySweden